Motif pummelled as FDA asks for more data on antibioticShares in UK biotech Motif Bio fell more than 50% after its much-delayed antibiotic was held up at Share XMotif pummelled as FDA asks for more data on antibiotichttps://pharmaphorum.com/news/motif-pummelled-as-fda-asks-for-more-data-on-antibiotic/
